Trial Information

Contrast Enhanced MRI of the Central Nervous System - Adults

People who have lesions of the brain or spine may be eligible for an MRI of the central nervous system. These people are asked to participate in a research study being conducted by Kingston Neurological Associates.

You may be eligible to participate in this study if you:

Are at least 18 years of age
Have been referred for a contrast-enhanced MRI of the central nervous system (CNS) based on current clinical symptoms or results of a previous imaging procedure
Are willing to undergo the routine contrast-enhanced MRI examination with gadoteridol and gadobutrol
Are willing and able to complete all study procedures

You may not participate in this study if you:

Have a history of severe allergic reaction to any allergen and contrast agents
Have any contraindication to the MRI examination or the use of Gd containing contrast agents
Have received any contrast agent within 24 hours prior to the study MRIs, or is scheduled to receive any contrast agent within 72 hours
Are considered clinically unstable (due to previous surgery, acute renal failure)
Are pregnant, breastfeeding, or intend to become pregnant during the study
Have participated in another research study within the last 30 days

Cindy Miller, Study Coordinator
Biomedical Research Alliance of New York
Kingston Neurological Associates
365 Broadway
Kingston, NY 12401
Phone: 845-331-5165
Fax: 845-331-6238
Email: nygal929@yahoo.com

View Map

Research Center Information: Biomedical Research Alliance of New York

If you would like to learn more about participating in this study, please send an email message using the form below.

Name:
Address:
City:
State:
Country:
Phone:
Email:
Message:

DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.